Announcements of individual stocks: Notice of revision of precautions for use of ibuprofen-containing product "Pain Relief Capsule a"
Thank you very much for your continued patronage of our products.
On October 8, 6th year of Reiwa, a notification regarding the revision of "Precautions for Use" (Pharmaceuticals Safety Bureau No. 1008-1 Director of Pharmaceutical Safety Measures, Ministry of Health, Labour and Welfare) was issued.
Therefore, we kindly ask you to refer to it for your future use. If you have any questions, please contact our customer service center for assistance.
Please note that it may take some time for products with revised (additional) precautions to reach you due to inventory distribution, so we appreciate your understanding.
【Our Customer Service Center】
Phone: 0120-5884-01 Reception hours: 9:00-17:00 (excluding Saturdays, Sundays, and holidays)
Record
1. Relevant product
| Therapeutic category | Product Name | Item |
|---|---|---|
| Antipyretic analgesic drug | Pain relief capsule A | 18 capsules |
2. Revision (additional notes) of 'Usage Precautions'Underlined section）
Revise (add) as follows
After revision | Before revision | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Consultation Sincerely yours 2. If the following symptoms appear after taking the medicine, it may be a side effect, so immediately stop taking it, and consult a doctor, dentist, pharmacist, or registered seller with this document.As is currently in effect Rarely, the following serious symptoms may occur.
| Consultation Sincerely yours 2. If the following symptoms appear after taking the medicine, it may be a side effect, so immediately stop taking it, and consult a doctor, dentist, pharmacist, or registered seller with this document.Abbreviation Rarely, the following serious symptoms may occur.
|
Above.
Share this page.
